ABUS
Arbutus Biopharma Corp
$4.80
0.00 (0.00%) Today
— up— down
Market Cap
$948M+55.3%
Revenue (TTM)
$193.73M+2889.9%
Net Income (TTM)
$162.48M
$162.48MEPS (TTM)
0.82
0.82Shares Out
197.54M
197.54MP/E Ratio
5.83
5.83Forward P/E
32.22
32.22Open
$4.80
$4.80Previous Close
$4.80
$4.80Day Range
$4.67 – $4.87
$4.67 – $4.8752-Week Range
$3.08 – $5.10
$3.08 – $5.10Beta
0.63
0.63Volume
3.30M
3.30MAvg Volume
2.18M
2.18MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ABUS
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Related
News
Buy the UK DIP? Defense stocks lifted by $20 billion spending boost as gilts come under fire
CNBC · 1h ago
Wall St futures slip as US-Iran tensions cloud Middle East peace prospects - Reuters
Reuters · 1h ago
The next Iran war may come sooner than you think - Reuters
Reuters · 2h ago
US and Iran enter technical talks to secure peace deal, shipping restart - Reuters
Reuters · 2h ago
Iran insists on keeping control over Hormuz, senior Iranian sources say - Reuters
Reuters · 2h ago